Crestline Investors, Inc.
10% owner at DNLI; 10% owner at Juno Therapeutics, Inc.
- Sold, on record
- $680M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jun 5, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- DNLIDenali Therapeutics Inc.10% owner
- Juno Therapeutics, Inc.10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Juno Therapeutics, Inc.16.6M shares
- DNLI5.8M shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Juno Therapeutics, Inc.UnusualMar 1 2016
Sold 8.6M shares at $39.00 ($335M)
Crestline Investors, Inc., 10% owner
Sold 33.4% of holdings ($1B position)17.2M shares leftFirst sale on recordFiling
- 2 Form 4 sale Juno Therapeutics, Inc.UnusualJul 13 +499 days
Sold 8M shares at $27.00 ($216M)
Crestline Investors, Inc., 10% owner
Sold 46.6% of holdings ($463M position)9.2M shares leftFiling
- 3 Form 4 sale DNLIPlan not statedFeb 26 +958 days
Sold 3.9M shares at $20.25 ($78.9M)
Crestline Investors, Inc., 10% owner
Sold 20% of holdings ($394M position)15.6M shares leftFirst sale on recordFiling
- 4 Form 4 sale DNLIPlan not statedJun 5 +100 days
Sold 1.9M shares at $25.75 ($49.5M)
Crestline Investors, Inc., 10% owner
Sold 12.4% of holdings ($401M position)13.6M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2020 | DNLI | 10% owner | Form 4 sale | 1.9M | $49.5M | 12.4% | Plan not stated | SEC |
| Feb 26, 2020 | DNLI | 10% owner | Form 4 sale | 3.9M | $78.9M | 20.0% | Plan not stated | SEC |
| Jul 13, 2017 | Juno Therapeutics, Inc. | 10% owner | Form 4 sale | 8M | $216M | 46.6% | Unusual | SEC |
| Mar 1, 2016 | Juno Therapeutics, Inc. | 10% owner | Form 4 sale | 8.6M | $335M | 33.4% | Unusual | SEC |